IMMUNODOMINANT TARGETS OF CMI TO CRYPTOSPORIDIUM
CMI 对隐孢子虫的免疫显性靶点
基本信息
- 批准号:7091583
- 负责人:
- 金额:$ 22.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-05-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:CryptosporidiumT lymphocytecell population studycell typecellular immunitycryptosporidiosiscytokineemerging infectious diseasegenetically modified animalshelper T lymphocytehost organism interactionimmunodeficiencyimmunologic memoryinterleukin 12laboratory mouseleukocyte activation /transformationlymphocyte proliferationmicroorganism immunologymucosal immunitypassive immunizationprotozoal antigen
项目摘要
DESCRIPTION (provided by applicant): Cryptosporidium parvum infections in immunocompromised individuals often develop into chronic, severe cryptosporidiosis that can become life-threatening. In conjunction with low CD4+ cell levels, insufficiency of other immune system factors are expected to contribute to infection chronicity in the immunodeficient host. In contrast, cytokines such as gamma interferon (IFN-gamma) have been implicated in control of infection in both adults and children. Elucidation of immune responses and identification of features of immune dysregulation, such as cytokine abnormalities or inability of T-cells to proliferate in response to key cryptosporidial antigens, might identify patients at high risk for cryptosporidiosis. It is hypothesized that infection resolution in the immunocompetent host is linked to specific antigens responsible for the activation of lymphocyte populations and induction of cytokines and allows for protection from subsequent infections. Consequently, a lack of response to these key antigens and development of certain cytokine profiles may lead to chronic, intractable infections and limited, if any, protective responses. We have recently developed a model useful for evaluating protective immunity to C. parvum infection in adult experimental animals. This model, which uses IL-12 deficient or "knockout" mice, is an important advance as previous tools were inadequate to effectively assess immunity. We now plan to use this model to determine the cell types and cytokines necessary for the generation and maintenance of protective immune responses. The necessity of subpopulation of lymphocytes will be determined by depletion of specific cell populations (e.g. CD4+, CD8+, and IEL cells) as well as key cytokines (IFN-gamma, IL-15 and IL-4) during primary and challenge infection of IL-12 knockout mice. To determine if protective responses identified by these experiments can be induced through immunization, immunodominant antigens (Cp40, Cp23, Cp17, Cp15, CpPO, CpP1, and CpP2) will be evaluated to determine if they can generate protective responses in our mouse vaccine model. This will be accomplished by immunizing mice with a DNA construct of these antigens, assessing their ability to elicit immune responses, and challenging mice with C. parvum to determine the degree of protection achieved.
描述(申请人提供):免疫受损患者的微小隐孢子虫感染通常发展为慢性、严重的隐孢子虫病,可危及生命。与低水平的CD4+细胞一起,其他免疫系统因子的不足预计会导致免疫缺陷宿主的感染慢性化。相比之下,细胞因子,如干扰素(干扰素),被认为与成人和儿童的感染控制有关。阐明免疫反应和识别免疫失调的特征,如细胞因子异常或T细胞对关键隐孢子虫抗原的反应不能增殖,可能会识别出隐孢子虫病的高危患者。假设具有免疫能力的宿主中的感染分解与负责激活淋巴细胞群体和诱导细胞因子的特定抗原有关,并允许保护其免受后续感染。因此,缺乏对这些关键抗原的反应和某些细胞因子谱的形成可能会导致慢性、难治性感染和有限的保护性反应。我们最近开发了一种模型,可用于评估成年实验动物对微小弧菌感染的保护性免疫。该模型使用了IL-12缺陷或“基因敲除”的小鼠,是一个重要的进步,因为以前的工具不足以有效地评估免疫力。我们现在计划使用这个模型来确定产生和维持保护性免疫反应所需的细胞类型和细胞因子。淋巴细胞亚群的必要性将取决于在IL-12基因敲除小鼠的初次和挑战感染过程中特定细胞群(如CD4+、CD8+和IEL细胞)以及关键细胞因子(干扰素-γ、IL-15和IL-4)的耗竭。为了确定这些实验确定的保护性反应是否可以通过免疫诱导,将对免疫优势抗原(Cp40、Cp23、Cp17、Cp15、CpPO、CpP1和CpP2)进行评估,以确定它们是否可以在我们的小鼠疫苗模型中产生保护性反应。这将通过用这些抗原的DNA结构免疫小鼠,评估它们引发免疫反应的能力,并用微小弧菌攻击小鼠来确定达到的保护程度来实现这一点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAN R MEAD其他文献
JAN R MEAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAN R MEAD', 18)}}的其他基金
Microbiome Impact on the Susceptibility and Severity to Cryptosporidium Infection
微生物组对隐孢子虫感染的易感性和严重程度的影响
- 批准号:
10252399 - 财政年份:2021
- 资助金额:
$ 22.06万 - 项目类别:
Microbiome Impact on the Susceptibility and Severity to Cryptosporidium Infection
微生物组对隐孢子虫感染的易感性和严重程度的影响
- 批准号:
10338198 - 财政年份:2021
- 资助金额:
$ 22.06万 - 项目类别:
Mucosal Immunity and the Role of TH1 Cytokines in a Model of Cryptosporidiosis
粘膜免疫和 TH1 细胞因子在隐孢子虫病模型中的作用
- 批准号:
8391629 - 财政年份:2010
- 资助金额:
$ 22.06万 - 项目类别:
Mucosal Immunity and the Role of TH1 Cytokines in a Model of Cryptosporidiosis
粘膜免疫和 TH1 细胞因子在隐孢子虫病模型中的作用
- 批准号:
8597404 - 财政年份:2010
- 资助金额:
$ 22.06万 - 项目类别:
Mucosal Immunity and the Role of TH1 Cytokines in a Model of Cryptosporidiosis
粘膜免疫和 TH1 细胞因子在隐孢子虫病模型中的作用
- 批准号:
8198365 - 财政年份:2010
- 资助金额:
$ 22.06万 - 项目类别:
Mucosal Immunity and the Role of TH1 Cytokines in a Model of Cryptosporidiosis
粘膜免疫和 TH1 细胞因子在隐孢子虫病模型中的作用
- 批准号:
8045925 - 财政年份:2010
- 资助金额:
$ 22.06万 - 项目类别:
IMMUNODOMINANT TARGETS OF CMI TO CRYPTOSPORIDIUM
CMI 对隐孢子虫的免疫显性靶点
- 批准号:
6532705 - 财政年份:1996
- 资助金额:
$ 22.06万 - 项目类别:
IMMUNODOMINANT TARGETS OF CMI TO CRYPTOSPORIDIUM
CMI 对隐孢子虫的免疫显性靶点
- 批准号:
7198162 - 财政年份:1996
- 资助金额:
$ 22.06万 - 项目类别:
IMMUNODOMINANT TARGETS OF CMI TO CRYPTOSPORIDIUM
CMI 对隐孢子虫的免疫显性靶点
- 批准号:
7585748 - 财政年份:1996
- 资助金额:
$ 22.06万 - 项目类别:
IMMUNODOMINANT TARGETS OF CMI TO CRYPTOSPORIDIUM
CMI 对隐孢子虫的免疫显性靶点
- 批准号:
2073113 - 财政年份:1996
- 资助金额:
$ 22.06万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 22.06万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 22.06万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 22.06万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 22.06万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 22.06万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 22.06万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 22.06万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 22.06万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 22.06万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 22.06万 - 项目类别:
Discovery Grants Program - Individual